Abstract
Both in patients and in experimental animals sepsis and endotoxemia are associated with increased production of nitric oxide (NO), documented by urinary excretion of N03 and elevated plasma levels of nitrite and nitrate (N02/ N03), the stable end-products of NO [1–3]. Results in previous reports suggest that NO may be responsible for hemodynamic and metabolic consequences of sepsis and endotoxemia, and that inhibition of NO synthesis may be beneficial during these conditions [4–6]. Results observed in two patients with septic shock following treatment with the NO synthase inhibitor NG-monomethyl-l-arginine (NMA) were interpreted as indicating that NO contributes to the pathogenesis of septic shock, and that inhibition of NO synthesis may be a therapeutic option in septic patients [7]. In contrast, several recent studies, including reports from our laboratory, suggest that inhibition of NO synthase activity during sepsis and endotoxemia may be detrimental. Thus, evidence of increased mortality, liver and lung injury, and decreased intestinal integrity has been reported following treatment with NO synthase inhibitors during sepsis and endotoxemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wagner DA, Young VR, Tannenbaum SR (1983) Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 80: 4518–4521
Stuehr DJ, Marietta MA (1985) Mammalian nitrate biosynthesis: mouse macrophages induce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82: 7738–7742
OchoaJB, Udekwu AO, BilliarTR, Curran RD, Cerra FB, Simmons RL, PeitzmanAB (1991) Nitrogen oxide levels in patients after trauma and sepsis. Ann Surg 214: 621–626
Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF (1990) NG- Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629–3632
Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF (1991) Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138
Klabunde RE, Ritger RC (1991) NG-Monomethyl-L-arginine ( NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178: 1135–1140
Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558
Tiao G, Rafferty J, Ogle C, Fischer JE, Hasseigren PO (1994) Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of TNF and 1L–6. Surgery 116: 332–338
Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL (1990) Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48: 565–569
Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly J (1994) Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129: 142–148
Waage A, Brandtzaeg P, Halstensen A, Kierluf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 169: 333–338
Sullivan JS, Kilpatrick L, Costarino AT, Lee SC, Harris MC (1992) Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 120: 510–515
Tracey KJ (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 35: 123–128.
Damas P, Ledoux D, Nys M, Vrindts Y, de Grou D, Franchimont P, Lamy M (1992) Cytokine serum levels during severe sepsis in human: IL-6 as a marker of severity. Ann Surg 215: 356–362
Stadler, Harbrecht BG, DiSilvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR (1993) Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 53: 165–172
Eigler A, Sinha B, Endres S (1993) Nitric oxide-releasing agents enhance cytokine- induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196: 494–501
Billiar TR, Curran RD, Stuehr DJ, Stadler J, Simmons RL, Murray SA (1990) Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun 168: 1034–1040
Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa J, Curran RD, Simmons RL (1992) Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 52: 390–394
Curran RD, Ferrari RJ, Kispert PH, Stadler J, Stuehr DJ, Simmons RL, Billiar TR (1991) Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 5: 2085–2092
Frederick JA, Hasselgren PO, Davis S, Higashiguchi T, Jacobs TD, Fischer JE (1993) Nitric oxide may upregulate in vivo hepatic protein synthesis during endotoxemia. Arch Surg 128: 152–157
McNurlan MA, Tomkins AM, Garlick PJ (1979) The effect of starvation on the rate of protein synthesis in rat liver and small intestine. Biochem J178: 373–379
Jepson MM, Pell JM, Bates PC, Millward DJ (1986) The effects of endotoxemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem J 235: 329–336
Sax HC, Talamini MA, Hasselgren PO, Rosenblum L, Ogle CK, Fischer JE (1988) Increased synthesis of secreted hepatic proteins during abdominal sepsis. J Surg Res 44: 109–116
Clowes GHA, Hirsch E, George BC, Bigatello LM, Mazuski JE, Villee CA (1985) Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-i. Ann Surg 202: 446–458
Moncada S, Palmer RMJ, Higgs EA (1988) The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12: 365–372
Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3,5-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946–955
Radowski MW, Palmer RMJ, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057–1058.
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
ShahNS, Nakayama DK, Jacob TD, Nishio I, ImaiT, Billiar TR, Exler R, Yousem SA, Motoyama EK, Peitzman AB (1994) Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 129: 158–164
Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129: 149–156
Brashers VL, Peach MJ, Rose EC (1988) Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium- dependent relaxation. J Clin Invest 82: 1495–1502
Archer SL, Tolins JP, Raij L, Weir EK (1989) Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium-derived relaxing factor. Biochem Biophys Res Commun 164: 1198–1205
Hutcheson IR, Whittle BJR, Boughton-Smith NK (1990) Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101: 815–820
Quaroni A, Wands J, Trelstad RL, Isselbacher KJ (1979) Epithelioid cell cultures from rat small intestine. J Cell Biol 80: 248–265
Johnson G, Tsao PS, Lefer AM (1991) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19: 244–249
Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker Bothelo LH (1991) Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 181: 1392–1397
Lyons CR, Orloff GJ, Cunningham JM (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370–6374
Lamas S, Marsden PA, Li GI, Tempst P, Michel T (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89: 6348–6352
Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, DiSilvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491–3495
Geller DA, Billiar TR (1993) Should surgeons clone genes? The strategy behind the cloning of the human inducible nitric oxide synthase gene. Arch Surg 128: 1212–1220
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide; physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142
Gross SS, Stuehr DJ, Kazuo A, Jaffe EA, Levi R, Griffith OW (1990) Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine, and NG-methylarginine. Biochem Biophys Res Commun 170: 96–103
Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS, McDonald H (1991) Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci 48: 69–75
Nussler AK, Billiar TR (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54: 171–178
Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722–25729
Cho HJ, Xie Q, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C (1992) Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176: 599–604
Stadler J, Bergonia HA, DiSilvio M, Sweetland MA, Billiar TR, Simmons RL, Lancaster JR (1993) Nonheme iron-nitrosyl complex formation in rat hepatocytes: detection by electron paramagnetic resonance spectroscopy. Arch Biochem Biophys 302: 4–11
Rogers NE, Ignarro LJ (1992) Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 189: 242–249
Assreuy J, Cunha FQ, Liew FY, Moncada S (1993) Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108: 833–837
Nava E, Palmer RMJ, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338: 1555–1557
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hasselgren, P.O., Fischer, J.E., Meyer, T.A., Tiao, G. (1995). Inhibition of Nitric Oxide Synthase During Sepsis and Endotoxemia May Be Detrimental. In: Schlag, G., Redl, H. (eds) Shock, Sepsis, and Organ Failure — Nitric Oxide. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79343-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-79343-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79345-5
Online ISBN: 978-3-642-79343-1
eBook Packages: Springer Book Archive